Anna A. Avagyan: Glad to Be Part of EHA Pediatric Hematology-Oncology Course
Anna A. Avagyan, Pediatric Hematologist/Oncologist at Pediatric Cancer and Blood Disorders Center of Armenia, shared a post on LinkedIn:
“For 20 years, the EHA Pediatric Hematology-Oncology Course has helped train generations of young hematologists. Seeing former participants return as faculty is probably the best reflection of its long-term impact.
For me, it is one of the most memorable pediatric hematology courses-strong academically, rich in discussion, shaped by outstanding faculty, and set in a place that makes the whole experience even more special.
Thank you to the European Hematology Association, the Specialized Working Group on Pediatrics, and the program directors led by Andrea Biondi and Adriana Bulduzzi for the excellent organization and for the opportunity to be part of this course.”
Stay updated with Hemostasis Today.
-
Sep 5, 2026, 16:28Jon Douglas: Imperial College London Review Maps Key Pathways in Autoimmune Thrombosis
-
Sep 5, 2026, 16:21Kelly Anderson: Bilateral Foot Pain and Purple Toes – Spotting Vascular Complications in Polycythemia Vera
-
Sep 5, 2026, 16:16Hazem Abosheaishaa: Beta-Blocker Selection Matters – Multi-Institutional Cohort Insights on PVT and Survival in Cirrhosis
-
Sep 5, 2026, 16:08Indre Ceponiene: Major Gaps in Secondary Cardiovascular Prevention Across Europe
-
Sep 5, 2026, 16:03W. Alberto Sifuentes Giraldo: Why Obstetric Cases Are Missed Under 2023 ACR/EULAR APS Criteria
-
Sep 5, 2026, 15:58Srikanth Nalla: A Case of Saddle Pulmonary Embolism
-
Sep 5, 2026, 15:55COPD-specific Pulmonary Embolism Diagnostic Strategy – Thrombosis and Haemostasis
-
Sep 5, 2026, 15:41Sam Tsimikas on Lp(a) HORIZON Topline Results – What Missed Endpoints Mean for Cardiovascular Risk
-
Sep 5, 2026, 15:32Stefano Garzon: SELUTION DeNovo HBR – Weren’t HBR Patients Supposed to Bleed More with DES?